证券代码：300610 证券简称：晨化股份 扬州晨化新材料股份有限公司 投资者关系活动记录表 编号：2025-010 投资者关系活动 类别 □特定对象调研 □分析师会议 □媒体采访 □业绩说明会 □新闻发布会 √路演活动 □现场参观 □其他 参与单位名称及 人员姓名 中信证券：孙臣兴；景林资产：蒋文超；姚泾河基金：孙伟； 汇华理财：于宏杰；康达新材：沈一涛。 时间 2025 年 5 月 29 日 地点 上海浦东香格里拉大酒店 上市公司接待人 员姓名 董事、副总经理、董事会秘书 吴达明 投资者关系活动 主要内容介绍 一、贵司将采用什么方式提升市值？ 证监会《上市公司监管指引第 10 号——市值管理》（以下简称 "《市值管理》"）中明确提出：上市公司应当聚焦主业，提升经营 效率和盈利能力，同时可以结合自身情况，促进上市公司投资价值合 理反映上市公司质量：并购重组；股权激励、员工持股计划；现金分 红；投资者关系管理；信息披露；股份回购；其他合法合规的方式。 公司自上市以来管理层一直高度重视市值管理工作，公司正依据 《市值管理》具体要求进行合规的市值管理。公司一贯坚持并将继续 专注主业、稳健经营，目前已落实的事项有： ...

证券代码：002657 证券简称：中科金财 北京中科金财科技股份有限公司投资者关系活动记录表 编号：043 | 投资者关系 | □特定对象调研 □分析师会议 | | --- | --- | | 活动类别 | □媒体采访 □业绩说明会 | | | □新闻发布会 □路演活动 | | | □现场参观 | | | ▇其他（线上会议） | | 活动参与人 | 上市公司参与人员： | | 员 | 公司董事长朱烨东 | | | 参与机构名称： | | | 民生证券；国盛证券；国泰基金；国金基金；鹏华基金；博远 | | | 基金；长城财富；建顺投资；华安基金；建信理财；建信基金； | | | 上银基金；华泰资产；博时基金；富国基金；银华基金；敦和 | | | 资产；望正资产；新华基金；中欧基金；人保资管；融通基金； | | | 富荣基金；大成基金；华宝基金；易方达基金；诺德基金；长 | | | 安基金；华商基金；南方基金；天弘基金；广发基金；诺安基 | | | 金等 | | 时间 | 2025 年 5 月 29 日-2025 年 6 月 2 日 | | 地点 | 线上会议 | | 形式 | 线上会议 | | | 一、中科金财 ...

Group 1: Core Product - Yilishu - Yilishu successfully passed the national medical insurance negotiation by the end of 2023, with expected domestic net sales exceeding 500 million CNY in 2024, and over 270,000 units to be shipped [3] - The initial plan for Yilishu's U.S. market launch was set for July 2024, but delays occurred due to packaging issues and supply chain challenges, with successful shipment to the U.S. from Germany by the end of May 2025 [3][4] - Acrotech, the partner company, has issued binding purchase orders for over 40,000 units of Yilishu for 2025, reflecting an improved market outlook [4] Group 2: International Expansion - In Europe, distribution rights for Yilishu are granted to partners, with sales contingent on obtaining medical insurance status [5] - The Japanese partner will independently conduct clinical trials for Yilishu, focusing on differentiated administration methods [5] - Other markets, including the Middle East and Southeast Asia, are in the stages of partner selection or product registration [5] Group 3: Supply Chain Optimization - The current supply chain for Yilishu involves complex coordination across China, the U.S., and Germany, leading to high production costs and long lead times [6] - Efforts are underway to optimize the supply chain, aiming to reduce costs by consolidating production within a single country [6] Group 4: Other Products and Innovations - The company is advancing the Dandjin Detox Capsule, currently in the data analysis phase after completing Phase 1 clinical trials, with plans to communicate with the CDE for the next trial phase [7] - The product Yinikang has seen lower-than-expected sales of over 40 million CNY in 2024, but significant growth is anticipated in 2025 [8] - The synthetic biology segment is expected to contribute positively to the company's performance, with new products anticipated in the second half of the year [10] Group 5: Research and Development Strategy - The company is cautious about the risks associated with developing innovative drugs, particularly First in Class (FIC) products, and is continuously evaluating the opportunities and risks of its pipeline [11] - Future clinical research for the drug F-652 will be prioritized in the U.S., while domestic trials will focus on specific indications [11] Group 6: Sales and Marketing Strategy - The company has established a global commercial division and BD center to enhance compliance and expand market reach [13] - New product introductions and partnerships are ongoing, including the acquisition of marketing rights for Bayer's products, aiming to diversify the oncology portfolio [13]

Group 1: Medical Business Growth - The three main channels of the medical business are expected to achieve quality growth in 2025, with overseas business maintaining stable growth despite some tariff uncertainties [1][2] - Domestic hospital business is entering a harvest period due to prior investments in channel construction and product adjustments, with core products like surgical combination packs performing strongly [1][2] Group 2: C-end Business Development - The C-end business is experiencing rapid growth, supported by a strong brand image and a wide member base, with over 17 million fans as of March 31, 2025 [3] - The company plans to accelerate capability building in the C-end market to capture new opportunities, expanding its product line beyond masks to include nasal care, medical personal care, and functional wipes [3] Group 3: Mergers and Acquisitions Strategy - The core principle of the company's investment and acquisition strategy is to align with its overall strategic goal of creating a "one-stop solution for global medical consumables" [4] - The acquisition of GRI in September 2024 has strengthened the company's overseas capacity and local operational capabilities, marking a significant step towards globalization [4] Group 4: Cotton Soft Towel Market - The cotton soft towel market is growing, with the industry scale reaching over 10 billion, indicating vast market potential [5] - The company has developed an integrated business plan for cotton soft towels, focusing on consumer education and product innovation to enhance market share [5] Group 5: Profitability Trends - The overall profitability of the two main businesses is expected to improve steadily in 2025, with the medical business's operating profit margin projected to increase from 7.6% in 2024 [6] - The cotton soft towel brand is seeing rising consumer recognition and improved product structure, leading to a favorable outlook for gross margins [6] Group 6: Recent Marketing Activities - The company has launched various marketing activities to enhance brand awareness, including a traceability system for cotton soft towels and collaborations with media for promotional content [7] - Notable marketing events include a factory visit by experts and a live interaction with brand ambassadors to engage consumers [7]

Company Overview - Jiuzhou Group was founded in 1993, focusing on smart distribution networks and energy sectors, and is a leading provider of new power and energy infrastructure [1] - The company is a national key high-tech enterprise and was successfully listed on the ChiNext in 2010 (stock code: 300040) [1] - Jiuzhou Group has established three core business segments: smart distribution networks, new energy, and comprehensive energy services [2] Business Performance - The company has over 40 subsidiaries across various provinces and regions in China, with a marketing service network covering 30 provinces and autonomous regions [2] - Jiuzhou Group's products and solutions are applied in multiple industries, including power, energy, metallurgy, petrochemicals, coal, ports, rail transit, data centers, and urban renovation projects [2] - The company has received numerous accolades, including being listed among the top 100 private technology companies in China and the top 500 energy companies [2] Smart Distribution Network Orders - The order amount for smart distribution network equipment in 2024 is expected to exceed 800 million yuan, representing a year-on-year growth of over 30% [4] - As of Q1 2025, the company has won bids totaling over 260 million yuan, marking a historical high for the same period [4] Accounts Receivable - The company has approximately 1 billion yuan in accounts receivable from national subsidies, with a typical delay of 2-3 years [5] - The likelihood of not receiving these subsidies is low, as all wind and solar projects have passed compliance checks [5] Asset Management Strategy - Jiuzhou Group plans to maintain its total equity capacity between 1.5GW and 2GW, focusing on long-term holdings for new projects while gradually selling older projects [6] - The company aims to sell 100% equity of new energy stations as products to realize resource premiums and equipment value [6] Market Trends and Challenges - The company anticipates that market reforms in electricity pricing will not adversely affect existing projects, as they can continue to use guaranteed pricing [8] - New projects may see a price drop of 0.03-0.05 yuan per kWh, but the industry can maintain reasonable profit margins through cost reductions [8] New Energy Development - As of the end of 2024, Jiuzhou Group has constructed and controlled new energy stations with a total installed capacity exceeding 2.7GW, with an additional 1GW in projects under construction [3] - The company has secured five heating asset concessions in rural areas and is in the process of obtaining necessary approvals for project connections [9] Future Growth Projections - The company has set ambitious growth targets for 2025: a 30% revenue increase in smart distribution networks, a 10% increase in new energy generation, and a 10% increase in comprehensive energy services [15] - The potential market for distributed wind and clean energy heating is vast, with nearly 3,000 towns in Northeast China, positioning Jiuzhou Group as a pioneer in this sector [14]

投资者关系活动记录表 投资者关系活动 类别 特定对象调研 分析师会议 媒体采访 业绩说明会新闻发布会 路演活动 现场参观 其他（券商策略会、电话会议） 参与机构名称 Khazanah Nasional Berhad(马来西亚主权财富基金）、民生证券、太平资 管、中信证券、兴证基金、阳光资产、鹏扬基金、佳琪资产等 时间 2025 年 5 月 28 日-29 日 地点及形式 线下会议 上市公司接待人 员姓名 董事会秘书 周帆女士 助理总裁 徐海波先生 投资者关系经理钟雷先生 投资者关系活动 主要内容介绍 1、公司在稳定币方面是否有应用和进展？ 答：作为金融科技领域的积极践行者，宇信科技正以金融机构深度 合作伙伴的角色，开展相关领域应用和布局。一方面，公司基于产业方 面的丰富经验正联合境外高校开展基于Web3技术的零售支付课题研究； 另一方面，公司依托在国内数字人民币与各金融机构对接应用经验，正 积极布局拓展境外数字法币业务。 2、公司数字人民币应用的进展？ 答：公司在数字人民币和更广泛的支付清算交易领域有广泛布局， 不仅局限于常见的应用场景，还涵盖诸多广义应用。 公司已有案例，帮助国有大行分行推广数币应用并落地消 ...

Group 1: Investor Relations Activity - The investor relations activity included a factory visit at the Adidas factory in Emei, Sichuan on May 29-30, 2025, attended by the company's chairman and management team [2] - Investors signed a commitment letter as per Shenzhen Stock Exchange regulations before participating in the factory tour [2] Group 2: Production and Operational Insights - The company is currently in a production peak season with a full order book, ensuring timely deliveries [2] - The first quarter of 2025 saw a decline in gross margin due to the ramp-up phase of new factories and the hiring of new employees, which affected operational efficiency [3] - The company plans to optimize training and enhance automation to improve operational efficiency in the new factories [3][7] Group 3: Market and Pricing Strategy - The company is monitoring the impact of U.S. tariff policies on Southeast Asian countries, with no significant changes in order volumes reported so far [2] - Average selling price fluctuations are influenced by customer and product mix changes, with a diversified brand strategy in place [5] Group 4: Automation and Cost Management - The company is investing in automation to reduce reliance on skilled labor and improve production efficiency, with over 500 intelligent cutting machines introduced in 2024 [6][7] - The procurement model is based on "production-driven purchasing," allowing for timely raw material procurement and minimizing waste [8] Group 5: Expansion and Management Efficiency - The company is expanding operations in Indonesia and China, with a focus on optimizing management processes to maintain operational efficiency across multiple locations [9] - The management team is experienced in the Indonesian market, and the company is confident in achieving operational targets as the new factories mature [4] Group 6: Financial Performance and Shareholder Returns - The company has a strong track record of cash dividends, with 2021 cash dividends accounting for approximately 89% of net profit, and 2023 dividends around 44% [12] - The company aims to balance shareholder returns with capital expenditure needs, with a significant amount of undistributed profits available for future dividends [12]

编号：2025-005 投资者关系活 动类别 特定对象调研 分析师会议 媒体采访 业绩说明会 新闻发布会 路演活动 现场参观 其他：电话会议 参与单位名称 及人员姓名 万家基金、华安基金、大成基金、长信基金、富国基金、交银 施罗德基金、摩根基金、南方基金、浦银安盛基金、德邦基金 、东吴基金、海富通基金、恒越基金、弘毅远方基金、华宝基 金、华夏基金、金鹰基金、宽源私募基金、利幄基金、诺安基 金、诺德基金、鹏华基金、鹏扬基金、泉果基金、睿智基金、 松熙私募基金、银华基金、瀛赐私募基金、长安基金、长城基 金、淡水泉投资、惠升投资、混沌投资、健顺投资、聚鸣投资 、纽富斯投资、奇盛投资、青骊投资、睿亿投资、喜世润投资 、姚泾河投资、益恒投资、域秀投资、展博投资、冲积资产、 见龙资产、南土资产、人保资产、新华资产、咏明资产、祐益 资产、招商信诺资产、浙商资管、野村东方资管、财通资管、 敦和资管、玖鹏资管、中银资管、国弘资本、太平洋保险、长 江养老、兴银理财、东北证券、东方财富证券、东莞证券、东 吴证券、国海证券、国联证券、国泰海通证券、华创证券、华 福证券、华金证券、华鑫证券、开源证券、广发证券、民生证 券、平安证券、山 ...

Group 1: Industry Standards and Impact - Several mandatory national standards for intelligent connected vehicles have been released, focusing on basic safety, such as GB44495-2024, GB44496-2024, and GB44497-2024 [2][3] - The introduction of these standards is expected to boost the company's testing business, as both testing enterprises and automakers will increase their R&D investments [2][3] Group 2: Competitors and Market Position - Major automakers with large self-built testing facilities include SAIC-GM, Changan Automobile, FAW, and BYD [4] - Despite having self-built facilities, automakers may still choose to utilize the company's testing grounds due to the diverse and advanced infrastructure available [4] Group 3: Future Plans and Acquisitions - The company plans to address the issues at the Hulunbuir winter testing facility within five years of its listing, with potential methods including business transfer or asset transfer [5] - Any acquisition matters will be disclosed in accordance with legal regulations [5] Group 4: Dividend Policy - The company has implemented cash dividends for four consecutive years, totaling approximately 300 million yuan, with a cash dividend ratio of 61.10% of the net profit attributable to shareholders for 2024 [6][7] - Future dividend plans will be based on long-term shareholder interests and the company's operational status [7] Group 5: Pricing and Discounts - The company maintains a fair pricing policy, providing discounts based on business scale and strategic relationships, without offering lower discounts to the controlling shareholder [8] Group 6: Capacity Utilization - There is potential for improvement in the road capacity utilization rate, with strategies including increasing vehicle numbers through refined management and extending operational hours [9] Group 7: Fixed Costs - The company's fixed costs primarily consist of asset depreciation, labor costs, and maintenance of green spaces and roads [10]

股票代码：000828 股票简称：东莞控股 编号：2025-002 | □特定对象调研 | □分析师会议 | 投资者关系活 | | --- | --- | --- | | □媒体采访 | □业绩说明会 | 动类别 | | □新闻发布会 | ☑路演活动 | | | □现场参观 | | | | （请文字说明其他活动内容） | □其他 | | | 光大证券资管、鹏扬基金、泰合资本等 | | 参与单位名称 | | | | 及人员姓名 | | 年 5 月 28 日 | 2025 | 时间 | | | 上海 | 地点 | | 董事、副总裁、董事会秘书：林永森先生 | | 上市公司接待 | | | | 人员姓名 | | | 1、除高速公路业务外，公司第二增长曲线的方向是什么？ | | | | 答：公司正积极推进投资并购，重点围绕综合交通、新能源 | | | | 及新质生产力产业链上下游进行研究，寻找细分行业龙头的 | | | 并购机会。 | | | | | 2、公司大股东持股较为集中，个人股东偏多，如何进行优化？ | | | 有无考虑采用可交债或其他方式进行减持。 | | | | | 答：公司正在积极推进投资者关系管理工作 ...